Bernard Rudnick

Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.

Axxia Pharmaceuticals LLC commercializes implantable, polymer-based drug delivery technology. It allows surgeons to remove and replace the implant at the end of its therapeutic life. The company is headquartered in Bel Air, MD.

Operative Experience, Inc. develops and markets medical simulators. Its products include Labor and delivery simulators, surgery simulators, and tactical casualty care simulators. The company was founded by Robert F. Buckman, Jr. and is headquartered in North East, MD,

Keiretsu Capital LLC (Keiretsu) is a Venture Capital firm, a subsidiary of Keiretsu Forum LLC founded in 2013 by Matthew le Merle and Randy Williams. The firm headquartered in Seattle, Washington.

Mid Atlantic Bio Angels (MABA) is an venture capital firm founded in 2012 by Yaniv Sneor, Bernard Rudnick and Stephen Goodman. It is headquartered in New York, New York.

Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA.

Sagemedic Corp. specializes in precision medicine for cancer patients. The American company's approach is designed to identify the most effective treatment options, overcoming the limitations of genomic testing. Sagemedic was founded by Christian Apfel and Brigitte Apfel, with Christian Apfel serving as CEO since incorporation.

Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE.